Forgot your password?

Forgot your username?

Synthetic Biologics, Inc. Biotech Specialty Pharma

155 Gibbs Street, Ste. 412
Rockville, MD 20850 USA
Click for website
Research Sector Biotech Specialty Pharma
Summary Description Biologics for the prevention/treatment of serious infectious and other diseases.

Click here for Financial Data Keywordsinfectious diseases, C. difficile, pertussis, Acinetobacter, multiple sclerosis, synthetic biologics, monoclonal antibodies, estriol, beta-lactamase oral enzyme, ibs, Intrexon


Biotechnology company focused on the development of biologics for prevention and treatment of serious infectious and other diseases.The company is developing an oral enzyme for the prevention of C. di......view more

Products / Services

1) Multiple Sclerosis - Trimesta (oral estriol) is in a Phase II clinical trial being evaluated for the treatment of relapsing-remitting multiple sclerosis. 2) Archaea-associated diseases (C-IBS,......view more

Technology / Differentiation

Trimesta (oral estriol) is an investigational oral drug being developed for the treatment of relapses in multiple sclerosis (MS) and cognitive dysfunction in MS. Estriol has been approved and marketed...view more

Market / Customers

Serious infectious diseases......view more

Analyst Coverage

Andrew Fein - H.C. Wainwright & Co. Sherry Grisewood, CFA - Wm. Smith & Co. Rahul Jasuja, PhD - Noble Financial Capital Markets Jason Kolbert - Maxim Group LLC Keith A. Markey, Ph.D. - Gri...view more